跳至主要内容
临床试验/NCT07358923
NCT07358923尚未招募不适用

Accuracy of Modified Milan Ultrasound Criteria in Assessing Disease Activity and Severity in Moderate-to-Severe Ulcerative Colitis: a Pilot Study

IRCCS San Raffaele0 个研究点目标入组 25 人开始时间: 2026年2月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
25

研究概览

简要总结

Longitudinal prospective monocentric observational study in which patients to start Mirikizumab for normal clinical practice will be followed for 24 weeks. Based on the findings in the comparison between US (IUS and TPUS) and endoscopy, the study aim is to build up a modified MUC (Milan Ultrasound Criteria) scoring system taking each colonic segment and the rectum into account, developing non-invasive quantitative ultrasound-based criteria to identify patients with active UC and assess its severity.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Confirmed diagnosis of UC according to ECCO guidelines
  • Patients with active moderate-to-severe disease defined as MES
  • Patients undergoing advanced therapies with mirikizumab according to clinical judgement
  • Patients who provide written informed consent

排除标准

  • Age < 18 years
  • Patients with unclassified colitis or other gastrointestinal conditions
  • Patients with current infections or other severe comorbidity, including liver, kidney or cardiac failure, which contraindicate the initiation of advanced therapy
  • Patients unable or unwilling to provide consent

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mariangela Allocca

MD, PhD

IRCCS San Raffaele

相似试验